BioSig Technologies Inc. (NASDAQ: BSGM), a Westport-based medical technology company focused on intracardiac signal visualization, has named Frederick Hrkac to the new role of executive vice president.
32-year career in medical device and electrophysiology business expansion for industry bellwethers; led multiple company exits including a $1B sale in 2018 Part of leadership team that grew Johnson & Johnson’s original cardiology/electrophysiology business from $22M to $500M in 7 yearsWestport, CT, Nov. 07, 2023 (GLOBE NEWSWIRE) Westport, CT, November 7, 2023 (GLOBE NEWSWIRE) BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to del
Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases , which amended. | March 31, 2023